Cutera, Inc. (CUTR)

Market Cap	38.92M
Revenue (ttm)	230.18M
Net Income (ttm)	-113.39M
Shares Out	19.96M
EPS (ttm)	-5.76
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,103,759
Open	2.280
Previous Close	2.300
Day's Range	1.900 - 2.360
52-Week Range	1.280 - 23.280
Beta	1.67
Analysts	Buy
Price Target	11.00 (+464.1%)
Earnings Date	May 7, 2024

About CUTR

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Mar 31, 2004
• Employees: 540
• Stock Exchange: NASDAQ
• Ticker Symbol: CUTR

Analyst Forecast

According to 5 analysts, the average rating for CUTR stock is "Buy." The 12-month stock price forecast is $11.0, which is an increase of 464.10% from the latest price.

Price Target

$11.0

(464.10% upside)

Analyst Consensus: Buy